36.70000 EUR
0.25
0.68%
Last update Dec 15, 7:31 PM CET
Main market
Day range
36.70000
36.85000
Previous close
36.95000
Open
36.85000
Access this stock data via API
Subscribe
Dermapharm Holding SE
36.70
0.25
0.68%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 272.1M 302.4M 290.7M 311.6M
Cost of revenue 88.0M 103.2M 97.5M 115.2M
Gross profit 184.1M 199.2M 193.2M 196.4M
Operating expense
Research & development
Selling general and admin
Other operating expenses 49.2M 49.3M -75.3M 49.6M
Operating income 44.5M 59.8M 45.7M 66.1M
Non operating interest income
Income 1.3M 2.4M -608K 5.3M
Expense 13.2M 12.9M 11.5M 17.9M
Other income expense
Pretax income 32.5M 49.7M 34.6M 46.8M
Tax provision 11.6M 16.5M 15.5M 14.0M
Net income 20.9M 33.2M 19.0M 32.8M
Basic EPS 0.4 0.6
Diluted EPS 0.4 0.6
Basic average shares 53.6M 53.9M
Diluted average shares 53.6M 53.9M
EBITDA 66.1M 82.5M 72.2M 85.5M
Net income from continuing op. 32.5M 49.7M 34.6M 46.8M
Minority interests 2K 208K 1.5M -376K
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours

14:59
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).